$PATH

UiPath, Inc. (PATH) Stock Has AI Potential, But Slowing Growth Keeps Investors Cautious

UiPath (NYSE:PATH) shares are down year-to-date, but Wall Street sentiment is improving. DA Davidson raised its price target to $16. Q2 revenue grew 13% YoY to $410M, with ARR up 12%. Q3 guidance is $440M-$445M. Hedge funds increased stakes, but short interest is high at 29%. Growth concerns persist due to AI competition and monetization uncertainties.

Original reporting
Published Sep 13, 2026, 1:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 13, 2026, 2:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UiPath, Inc. (PATH) Stock Has AI Potential, But Slowing Growth Keeps Investors Cautious — source image
Decision brief

The 30-second read

$PATHBullishHigh
01

Why it matters

The earnings beat and guidance raise expectations for faster AI‑driven growth, though execution risk remains.

02

Market read

Fresh earnings and guidance provide a concrete catalyst for PATH, likely influencing short‑term price action.

03

What to watch

Potential pricing pressure from hyperscalers and AI‑native orchestration platforms.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

UiPath has been underperforming YTD, but recent AI‑focused initiatives and institutional buying are shifting sentiment.

Company-level read

Ticker impact

$PATHBullishHigh confidence
Context

UiPath reported Q2 FY2027 revenue up 13% YoY to $410M and raised FY2027 revenue guidance to $1.789B-$1.794B.

Expected impact

Potential short-term rally as investors reprice higher growth expectations.

Evidence & confidence

Robust revenue growth and upgraded price target indicate improved outlook, outweighing short‑interest concerns.

Market effects

RPA sector may see renewed interest as AI integration gains traction.

U.S. tech stocks could benefit from positive earnings spillover.

Highlights competitive pressure on automation vendors worldwide.

Counterpoint

High short interest (29%) and uncertain AI monetization could limit upside.

Key entities

  • DA Davidson

    Raised price target to $16 on Q2 results.

  • Rima Senvest Management

    Increased stake by 56% to $131.36M.

Related articles

$PATHMedAI 8/10

UiPath Stock Rises 2.2%—Why Its 89% AI Survey Result Isn’t Revenue Yet

UiPath (PATH) shares rose 2.21% to $13.87 on Thursday, though still down 23.9% from pre-earnings levels. A company-sponsored survey showed 89% of respondents with embedded orchestration met ROI expectations, but this doesn't guarantee revenue growth. Q2 revenue increased 13% to $410M, with ARR up 12% to $1.938B. Management expects Q3 ARR of $1.992B-$1.997B. Investors await evidence of monetization at Investor Day on September 22.

$PATHHigh

Citi Just Upgraded UiPath Stock. Here's Why.

Citi's Yitchuin Wong upgraded UiPath (PATH) to 'Buy' with a $23 price target, citing its AI orchestration role and 60% upside potential. PATH stock has fallen 25% year-to-date after missing Q3 revenue estimates, but Wong sees long-term value in its AI integration and raised full-year revenue outlook to $1.789B, exceeding Zacks' consensus.

$PATHHighAI 8/10

UiPath (PATH) Q2 2027 Earnings Call Transcript

UiPath (PATH) reported Q2 2027 revenue of $410M, up 13% YoY, with ARR at $1.938B, growing 12%. Non-GAAP operating income was $89M (22% margin). Cloud ARR grew 19% to $1.3B. Full-year revenue guidance is $1.789B-$1.794B. The company highlighted AI integration in deals and operational improvements, including a 60% reduction in implementation effort.

$PATHHighAI 8/10

PATH Stock Slides As Earnings Disappoint And Wall Street Stays Cautious

UiPath Inc. (PATH) stock fell 3.44% on September 9, 2026, extending a 27% decline since late August. The drop follows a disappointing earnings reaction, with revenue of $410.3M and net income of $36.1M for Q2 2026. Bank of America raised its price target to $15 but maintained an Underperform rating, citing cautious AI growth expectations. Insider sales and weak chart patterns add to trader skepticism.

$PATHMed

PATH Stock Slides As Traders Question AI Growth Story

UiPath Inc. (NYSE: PATH) shares fell 3.44% on September 9, 2026, amid concerns over automation demand and AI competition. The stock dropped 25% in a week following its earnings release, with revenue at $410.3M, net income at $36.1M, and a P/E ratio of 25. Bank of America raised its price target to $15 but maintained an Underperform rating, citing doubts about growth durability.